King Pharmaceuticals obtained FDA clearance for Embeda, which is extended-release morphine for pain. To prevent abuse, the morphine's effect is reversed when the capsule is crushed or chewed, but there is no concrete evidence that the drug truly is tamper-resistant, the company said.

Full Story:
Bloomberg, Reuters

Related Summaries